| Nome |
# |
|
Multimodality imaging of adult rhabdomyosarcoma: the added value of hybrid imaging, file de164a8f-1019-73f5-e053-d805fe0a7be4
|
114
|
|
Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations, file 4b7ba300-eb07-422b-b443-10cc19f2cfa1
|
40
|
|
Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors, file de164a8f-2f0c-73f5-e053-d805fe0a7be4
|
32
|
|
Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC, file de164a8f-3372-73f5-e053-d805fe0a7be4
|
32
|
|
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial, file de164a8f-282b-73f5-e053-d805fe0a7be4
|
28
|
|
Nivolumab for relapsed/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial, file de164a8e-c681-73f5-e053-d805fe0a7be4
|
26
|
|
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer(ASCEND-1): update results from the multicenter, open-label, phase 1 trial., file de164a8e-c48f-73f5-e053-d805fe0a7be4
|
25
|
|
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial, file d4238a46-c7db-4b9b-a89f-eb83bc2330ec
|
23
|
|
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma, file de164a8f-1025-73f5-e053-d805fe0a7be4
|
23
|
|
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma, file 3eed5850-a570-4cb0-a3d6-8b8d3c830ac8
|
22
|
|
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial, file f81ec15c-1fde-4f17-a5c8-86a313558de7
|
18
|
|
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma, file de164a8f-1d90-73f5-e053-d805fe0a7be4
|
17
|
|
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: when, why and what?, file de164a8f-248f-73f5-e053-d805fe0a7be4
|
17
|
|
Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial, file 6fef1649-b19a-4bc4-b325-318d038ac782
|
15
|
|
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma, file de164a8e-ef7e-73f5-e053-d805fe0a7be4
|
15
|
|
CAR T-Cell Therapies in Italy: Patient Access Barriers and Recommendations for Health System Solutions, file 47684e38-30de-4c43-897a-3da3e7c9a4d5
|
11
|
|
Phase III multinational, randomized, double-blind, placebo-controlled study of Tivantinib (ARQ 197) plus Erlotinib vs Erlotinib alone in previously treated patients with locally advanced or metastatic nonsquamous non-small-cell lung cancer., file de164a8e-bfa6-73f5-e053-d805fe0a7be4
|
11
|
|
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma, file de164a8f-2cd9-73f5-e053-d805fe0a7be4
|
11
|
|
CheckMate 040 cohort 5: a phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and child-plugh B cirrhosis, file de164a8f-2cf0-73f5-e053-d805fe0a7be4
|
11
|
|
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi, file de164a8f-2c18-73f5-e053-d805fe0a7be4
|
10
|
|
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi, file df623152-3f25-429b-8d14-f2996452a204
|
9
|
|
Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma : Final results of a multicenter phase II study, file de164a8e-c489-73f5-e053-d805fe0a7be4
|
8
|
|
Salvage Therapy for Hodgkin's Lymphoma: A Review of Current Regimens and Outcomes, file de164a8f-0d08-73f5-e053-d805fe0a7be4
|
8
|
|
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years, file de164a8f-24e4-73f5-e053-d805fe0a7be4
|
7
|
|
Single-cell profiling reveals the dynamics of cytomegalovirusspecific T-cells in haploidentical hematopoietic stem cell transplantation, file de164a8f-2b71-73f5-e053-d805fe0a7be4
|
7
|
|
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide, file 028a5f82-24de-4d21-9238-e37bdc069601
|
6
|
|
Characterisation of the immune-related transcriptome in resected biliary tract cancers, file de164a8e-be72-73f5-e053-d805fe0a7be4
|
6
|
|
Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1 in patients with hepatocellular carcinoma, file de164a8e-c24e-73f5-e053-d805fe0a7be4
|
6
|
|
Clinical Effects of Driver Somatic mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With allogeneic Hematopoietic Stem-Cell Transplantation, file de164a8e-c463-73f5-e053-d805fe0a7be4
|
6
|
|
Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working Group, file 43ac9e63-a294-4629-824f-f0ffcc22d57e
|
5
|
|
AML-389 Phase 1/2 Study of SEL24/MEN1703, a First-in-Class Dual PIM/FLT3 Kinase Inhibitor, in Patients With IDH1/2-Mutated Acute Myeloid Leukemia: The DIAMOND-01 Trial, file 4bfbb191-6d5b-4304-b0ee-42e91885b6be
|
5
|
|
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics, file 7ce563df-0bfa-41c4-aad0-709ff8664321
|
5
|
|
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma, file de164a8e-c5d9-73f5-e053-d805fe0a7be4
|
4
|
|
Brentuximab Vedotin with chemotherapy for stage III or IV Hodgkin’s Lymphoma, file de164a8e-c67a-73f5-e053-d805fe0a7be4
|
4
|
|
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas, file de164a8f-2154-73f5-e053-d805fe0a7be4
|
4
|
|
Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer, file de164a8f-3789-73f5-e053-d805fe0a7be4
|
4
|
|
Prostatic stromal tumor with fatal outcome in a young man : histopathological and immunohistochemical case presentation, file de164a8f-384d-73f5-e053-d805fe0a7be4
|
4
|
|
Surgical management of BRCA-mutation carriers: A single institution experience, file 5fdc31fd-881d-4e64-a71d-b5706735c33f
|
3
|
|
Comment on: "Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction", file de164a8f-283c-73f5-e053-d805fe0a7be4
|
3
|
|
Nomograms predicting local and distant recurrence and disease-specific mortality for R0/R1 soft tissue sarcomas of the extremities, file 1283967c-9900-449f-b319-a689a551703c
|
2
|
|
COVID-19 Sequelae and the Host Pro-Inflammatory Response: An Analysis From the OnCovid Registry, file 363307f4-a395-4d23-94e0-db9b2818fe08
|
2
|
|
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial, file de164a8e-e74d-73f5-e053-d805fe0a7be4
|
2
|
|
The radiologist empowerment through virtual multidisciplinary tumor boards: The commitment of oncologic care during COVID-19 pandemic, file de164a8f-168a-73f5-e053-d805fe0a7be4
|
2
|
|
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score, file de164a8f-20ba-73f5-e053-d805fe0a7be4
|
2
|
|
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial, file de164a8f-2c16-73f5-e053-d805fe0a7be4
|
2
|
|
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study, file de164a8f-2c92-73f5-e053-d805fe0a7be4
|
2
|
|
Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy, file de164a8f-3029-73f5-e053-d805fe0a7be4
|
2
|
|
Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort, file 120090b1-9c29-4d5a-9f90-c59a63e5b3ae
|
1
|
|
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds, file 2c21c481-76e7-4f84-8208-a559a5716186
|
1
|
|
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment, file 2f2a6898-4c20-4631-ad58-63bb3c69953e
|
1
|
|
EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide, file 35854904-b557-40ad-9426-55e52e636a18
|
1
|
|
HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma, file 61bc22f2-d02e-44b7-9f1e-6db35be50820
|
1
|
|
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer, file 766ebac5-b315-4679-97d4-12825b888d64
|
1
|
|
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma, file 92e956a8-a983-4055-9335-ec82dd24af8a
|
1
|
|
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study, file a4a889a5-bd12-47d9-be1e-f0e0217e7bea
|
1
|
|
Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma : Final results of a multicenter phase II study, file bd30e9e6-3860-4b56-a8f7-dd5ae1dcc53b
|
1
|
|
PRECLINICAL ASSESSMENT OF VOLUMETRIC MODULATED ARC THERAPY FOR TOTAL MARROW IRRADIATION, file de164a8e-bb8d-73f5-e053-d805fe0a7be4
|
1
|
|
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma, file de164a8e-bb93-73f5-e053-d805fe0a7be4
|
1
|
|
Early Surgical Experience with Minimally Invasive Percutaneous Approach for Patients with Metastatic Epidural Spinal Cord Compression (MESCC) to Poor Prognoses, file de164a8e-bc11-73f5-e053-d805fe0a7be4
|
1
|
|
Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy, file de164a8e-bc1c-73f5-e053-d805fe0a7be4
|
1
|
|
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients, file de164a8e-bc20-73f5-e053-d805fe0a7be4
|
1
|
|
C-11-labeled methionine and evaluation of malignant pleural mesothelioma, file de164a8e-bc21-73f5-e053-d805fe0a7be4
|
1
|
|
Primary refractory and early-relapsed Hodgkin's lymphoma : strategies for therapeutic targeting based on the tumour microenvironment, file de164a8e-bc55-73f5-e053-d805fe0a7be4
|
1
|
|
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in a observational study, file de164a8e-bc7d-73f5-e053-d805fe0a7be4
|
1
|
|
Metastasis of hepatocellular carcinoma to the heart: A case report and review of the literature, file de164a8e-bcbc-73f5-e053-d805fe0a7be4
|
1
|
|
Phase II study of Afatinib,an irreversibile ErbB family blocker, in EGFR Fish-positive Non-Small-Cell Lung Cancer, file de164a8e-bd7a-73f5-e053-d805fe0a7be4
|
1
|
|
Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer, file de164a8e-bd99-73f5-e053-d805fe0a7be4
|
1
|
|
Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution, file de164a8e-bda8-73f5-e053-d805fe0a7be4
|
1
|
|
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma, file de164a8e-be66-73f5-e053-d805fe0a7be4
|
1
|
|
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy, file de164a8e-be67-73f5-e053-d805fe0a7be4
|
1
|
|
Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review., file de164a8e-bee6-73f5-e053-d805fe0a7be4
|
1
|
|
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma Feasibility and tolerability in elderly and chemotherapy-ineligible patients, file de164a8e-bf0e-73f5-e053-d805fe0a7be4
|
1
|
|
Insulin-Like Growth Factor-1 Receptor and Phosphorylated AKT-Serine 473 Expression in 132 Resected Thymomas and Thymic Carcinomas, file de164a8e-bf14-73f5-e053-d805fe0a7be4
|
1
|
|
Re-irradiation of metastatic spinal cord compression: A feasibility study by volumetric-modulated arc radiotherapy for in-field recurrence creating a dosimetric hole on the central canal, file de164a8e-bf16-73f5-e053-d805fe0a7be4
|
1
|
|
Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy, file de164a8e-bf2a-73f5-e053-d805fe0a7be4
|
1
|
|
Tumor-derived PGD2 and NKp30 –B7H6 engagement drives an immunosuppressive ILC2-MDSC axis, file de164a8e-bfe3-73f5-e053-d805fe0a7be4
|
1
|
|
Pathological characterization of nivolumab –related liver injury in a patient with glioblastoma, file de164a8e-bff9-73f5-e053-d805fe0a7be4
|
1
|
|
Genomic integration of HHV-6 mimicking viral reactivation after autologous stem call transplantation, file de164a8e-c09c-73f5-e053-d805fe0a7be4
|
1
|
|
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art, file de164a8e-c0f0-73f5-e053-d805fe0a7be4
|
1
|
|
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide, file de164a8e-c119-73f5-e053-d805fe0a7be4
|
1
|
|
Survival Outcome and Prognostic Factors After Pulmonary Metastasectomy in Sarcoma Patients A 18-Year Experience at a Single High-volume Referral Center, file de164a8e-c137-73f5-e053-d805fe0a7be4
|
1
|
|
Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma, file de164a8e-c13e-73f5-e053-d805fe0a7be4
|
1
|
|
Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: a case report on the therapeutic regimen, file de164a8e-c1e7-73f5-e053-d805fe0a7be4
|
1
|
|
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients, file de164a8e-c209-73f5-e053-d805fe0a7be4
|
1
|
|
Outcome Evaluation of HER2 Breast Cancer Patients with Limited Brain Metastasis, file de164a8e-c21d-73f5-e053-d805fe0a7be4
|
1
|
|
Role of naïve-derived T memory stem cells in T cell reconstitution following allogeneic transplantation, file de164a8e-c299-73f5-e053-d805fe0a7be4
|
1
|
|
Retroperitoneal Sarcoma: Is It Time to Change the Surgical Policy?, file de164a8e-c2b0-73f5-e053-d805fe0a7be4
|
1
|
|
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme, file de164a8e-c2cd-73f5-e053-d805fe0a7be4
|
1
|
|
Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical transplantation, file de164a8e-c331-73f5-e053-d805fe0a7be4
|
1
|
|
The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide, file de164a8e-c332-73f5-e053-d805fe0a7be4
|
1
|
|
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis, file de164a8e-c3cb-73f5-e053-d805fe0a7be4
|
1
|
|
Bone Marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide, file de164a8e-c3f2-73f5-e053-d805fe0a7be4
|
1
|
|
Developing an adolescent and young adult (AYA) cancer program in an Italian adult high-volume cancer center., file de164a8e-c42c-73f5-e053-d805fe0a7be4
|
1
|
|
CHECKMATE 040: EFFICACY, HEPATIC SAFETY, AND BIOMARKERS OF NIVOLUMAB plus IPILIMUMAB COMBINATION THERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA, file de164a8e-c587-73f5-e053-d805fe0a7be4
|
1
|
|
Phase II study of Pemetrexed and Carboplatin plus Bevacizumab as first-line therapy in malignant pleural mesothelioma, file de164a8e-c5df-73f5-e053-d805fe0a7be4
|
1
|
|
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography, file de164a8e-de5c-73f5-e053-d805fe0a7be4
|
1
|
|
An exploratory biomarker study in metastatic tumors from colorectal cancer patients treated with bevacizumab, file de164a8e-f2e1-73f5-e053-d805fe0a7be4
|
1
|
|
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis., file de164a8e-f722-73f5-e053-d805fe0a7be4
|
1
|
|
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer, file de164a8f-0748-73f5-e053-d805fe0a7be4
|
1
|
|
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications, file de164a8f-0ff3-73f5-e053-d805fe0a7be4
|
1
|
| Totale |
674 |